References
- Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74
- Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum hemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008;22:999–1012
- Thomas J, Paranjothy S. Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. National Sentinel Caesarean Section Audit Report. RCOG Press; 2001. Available from: https://doi.org/http://www.ans.gov.br/portal/site/_hotsite_parto_2/publicacoes/RCOG_2001_AC.pdf [last accessed 12 Feb 2013]
- Cai WW, Marks JS, Chen CH, et al. Increased cesarean section rates and emerging patterns of health insurance in Shanghai, China. Am J Public Health 1998;88:777–80
- Begley CM, Gyte G, Devane D, et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2011;11:CD007412
- McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004;1:CD000201
- Carey M. Adverse cardiovascular sequelae of ergometrine. Br J Obstet Gynaecol 1993;100:865
- Tuncalp O, Hofmeyr GJ, Gulmezoglu AM. Prostaglandins for preventing postpartum hemorrhage. Cochrane Database Syst Rev 2012;8:CD000494
- Chong YS, Su LL, Arulkumaran S. Current strategies for the prevention of postpartum hemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 2004;16:143–50
- Schramme AR, Pinto CR, Davis J, et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses. Equine Vet J 2008;40:658–61
- Boucher M, Horbay GL, Griffin P, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 1998;18:202–7
- Dansereau J, Joshi AK, Helewa ME, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999;180:670–6
- Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
- Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: http://www.cochrane-handbook.org/
- Elgafor el Sharkwy IA. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study. Arch Gynecol Obstet 2013;288:1231–6
- Moertl MG, Friedrich S, Kraschl J, et al. Hemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomized trial. BJOG 2011;118:1349–56
- Reyes OA, Gonzalez GM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia: a double-blind randomized controlled trial. J Obstet Gynaecol Can 2011;33:1099–104
- Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum hemorrhage following caesarean section: the results of a double-blind randomized trial. BJOG 2010;117:929–36
- Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet 2009;280:707–12
- Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynaecol Can 2004;26:481–8
- Askar AA, Ismail MT, El-Ezz AA, Rabie NH. Carbetocin versus syntometrine in the management of third stage of labor following vaginal delivery. Arch Gynecol Obstet 2011;284:1359–65
- Su LL, Rauff M, Chan YH, et al. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery-a double-blind randomized controlled trial. BJOG 2009;116:1461–6
- Nirmala K, Zainuddin AA, Ghani NA, et al. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J Obstet Gynaecol Res 2009;35:48–54
- Leung SW, Ng PS, Wong WY, Cheung TH. A randomized trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG 2006;113:1459–64
- Del Angel García G, Garcia-Contreras F, Constantino-Casas P, et al. Economic evaluation of carbetocine for the prevention of uterine atony in patients with risk factors in Mexico. Value Health 2006;9:A254